Lee Equity to sell urology platform for $1.9bn to Cardinal Health; Bain, Arlington, Revelstoke invest in immunotherapy; H1 healthcare deals that mattered

In urology dealmaking, the landscape is highly fragmented and includes profitable ancillary services for diverse revenue streams.